ALBODE Trademark

Trademark Overview

On Friday, May 28, 2010, a trademark application was filed for ALBODE with the United States Patent and Trademark Office. The USPTO has given the ALBODE trademark a serial number of 85050323. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 13, 2014. This trademark is owned by Glaxo Group Limited. The ALBODE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
albode

General Information

Serial Number85050323
Word MarkALBODE
Filing DateFriday, May 28, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 13, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 12, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 2, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, January 13, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 13, 2014ABANDONMENT - NO USE STATEMENT FILED
Saturday, June 1, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 31, 2013EXTENSION 5 GRANTED
Wednesday, May 29, 2013EXTENSION 5 FILED
Wednesday, May 29, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, December 1, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 30, 2012EXTENSION 4 GRANTED
Wednesday, November 28, 2012EXTENSION 4 FILED
Wednesday, November 28, 2012TEAS EXTENSION RECEIVED
Saturday, June 2, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 1, 2012EXTENSION 3 GRANTED
Friday, May 25, 2012EXTENSION 3 FILED
Friday, May 25, 2012TEAS EXTENSION RECEIVED
Friday, November 18, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 17, 2011EXTENSION 2 GRANTED
Tuesday, November 15, 2011EXTENSION 2 FILED
Tuesday, November 15, 2011TEAS EXTENSION RECEIVED
Friday, June 10, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 9, 2011EXTENSION 1 GRANTED
Monday, June 6, 2011EXTENSION 1 FILED
Thursday, June 9, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 6, 2011TEAS EXTENSION RECEIVED
Tuesday, December 7, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 12, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 12, 2010PUBLISHED FOR OPPOSITION
Thursday, September 9, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, September 9, 2010ASSIGNED TO LIE
Thursday, August 26, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 26, 2010ASSIGNED TO EXAMINER
Wednesday, June 2, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 1, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

albode pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic